Orphagen Pharmaceuticals

Orphagen Pharmaceuticals is a pioneer in screening, discovering, and developing ligands that modulate orphan or underexplored members of the nuclear receptor family. The company focuses primarily on small-molecule drug discovery and breakthrough therapies for inflammatory diseases and oncology.